Boesen Biotech ApS — Credit Rating and Financial Key Figures
CVR number: 39142635
Lipkesgade 25, 2100 København Ø
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -13.61 | -21.21 | -33.55 | -33.79 | -28.05 |
| EBIT | -13.61 | -21.21 | -33.55 | -33.79 | -28.05 |
| Other financial income | 156.98 | 4 759.83 | 10 478.68 | 29.93 | 60.50 |
| Other financial expenses | - 145.43 | -1 915.25 | - 129.95 | -5 536.56 | -5 423.22 |
| Reduction non-current investment assets | 1 399.52 | ||||
| Net income from associates (fin.) | 32.64 | 77.53 | -11.03 | ||
| Pre-tax profit | -2.06 | 2 823.38 | 10 347.83 | -5 462.89 | -4 002.27 |
| Income taxes | 0.26 | - 514.07 | -2 266.97 | 34.77 | |
| Net earnings | -1.80 | 2 309.30 | 8 080.86 | -5 462.89 | -3 967.50 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 40.00 | 93.44 | 183.86 | 178.43 | |
| Investments total | 40.00 | 93.44 | 183.86 | 178.43 | |
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 38.60 | 26.38 | 515.55 | 1 822.47 | 3 357.58 |
| Current other receivables | 386.99 | 58.32 | |||
| Current deferred tax assets | 3.13 | 1.91 | 0.74 | ||
| Short term receivables total | 428.73 | 26.38 | 515.55 | 1 824.38 | 3 416.64 |
| Other current investments | 3 290.49 | 6 469.75 | 15 609.66 | 7 353.24 | 1 345.81 |
| Cash and bank deposits | 13.40 | 5.38 | 14.76 | 1 747.62 | 453.06 |
| Cash and cash equivalents | 3 303.89 | 6 475.13 | 15 624.42 | 9 100.86 | 1 798.87 |
| Balance sheet total (assets) | 3 732.62 | 6 541.51 | 16 233.42 | 11 109.09 | 5 393.94 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Other reserves | 117.65 | ||||
| Retained earnings | - 275.07 | - 276.87 | 2 032.43 | 10 113.29 | 4 532.75 |
| Profit of the financial year | -1.80 | 2 309.30 | 8 080.86 | -5 462.89 | -3 967.50 |
| Shareholders equity total | - 226.87 | 2 082.43 | 10 163.29 | 4 700.40 | 732.90 |
| Non-current owed to group member | 3 940.74 | 3 930.82 | 3 789.37 | 4 234.28 | 4 406.79 |
| Non-current liabilities total | 3 940.74 | 3 930.82 | 3 789.37 | 4 234.28 | 4 406.79 |
| Current trade creditors | 18.75 | 18.75 | 18.75 | 18.75 | 18.75 |
| Current owed to group member | 2 155.66 | 235.50 | |||
| Short-term deferred tax liabilities | 509.50 | 2 262.01 | |||
| Current liabilities total | 18.75 | 528.25 | 2 280.76 | 2 174.41 | 254.25 |
| Balance sheet total (liabilities) | 3 732.62 | 6 541.51 | 16 233.42 | 11 109.09 | 5 393.94 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.